Nawah Scientific, an Egypt-based life sciences and diagnostics company, has raised $23 million in Series A funding to expand its laboratory infrastructure and strengthen scientific research capabilities across Africa and the Middle East.
The funding reflects growing momentum in African tech funding and highlights increasing investor interest in biotech and deep-tech startups on the continent.
Nawah Scientific Funding: Key Details
Nawah Scientific’s $23 million Series A round was raised through a mix of equity and debt financing, placing it among the most notable African startup funding rounds in 2025.
Who Provided the Funding?
The round was led by Life Ventures Holding, with participation from:
- Den Ventures
- Empire M
- AfricInvest
- Elsewedy
- Banks and angel investors
This deal strengthens Nawah Scientific’s position within Africa’s growing healthtech and biotech ecosystem.
How Nawah Scientific Plans to Use the Funding
Expanding Research and Laboratory Capacity
Nawah Scientific plans to use the funding to:
- Expand laboratories in Egypt and Saudi Arabia
- Establish a large R&D hub in Rwanda
- Scale its cloud-based laboratory platform
- Support expansion into Europe and North Africa
This aligns with broader trends in healthcare innovation in Africa and increased investment in research infrastructure.
Supporting Life Sciences and Diagnostics in Africa
Strengthening Africa’s Research Ecosystem
Nawah Scientific provides integrated research, diagnostics, and laboratory services to pharmaceutical companies, research institutions, and healthcare organisations across multiple countries.
Core service areas include:
- Clinical and biomedical research
- Pharmaceutical and biotech testing
- Food and environmental analysis
- Diagnostics and laboratory services
By scaling locally, the company reduces dependence on overseas labs and supports faster innovation — a key theme across African deep-tech startups.
Why Nawah Scientific’s Funding Matters
Growing Momentum for African Biotech Startups
Investment in African biotech and life sciences startups has increased as investors diversify beyond fintech.
Nawah Scientific’s funding highlights:
- Rising confidence in African scientific talent
- Increased demand for local diagnostics and R&D
- A shift toward capital-intensive innovation sectors
This mirrors patterns seen in other African startup investment stories covered on Techawk.
What’s Next for Nawah Scientific?
Scaling Across Africa and Beyond
With new capital, Nawah Scientific is expected to:
- Deepen partnerships with global pharmaceutical companies
- Support more clinical trials and research projects
- Invest in laboratory automation and digital tools
The company’s expansion could help position Africa as a stronger player in global scientific research.
Nawah Scientific’s $23 million Series A funding marks a major milestone for Africa’s life sciences and diagnostics sector. As startup funding in Africa continues to grow, companies like Nawah Scientific are helping reshape the continent’s innovation landscape.
